Robert H. Jones

机构：Velindre NHS Trust, Cardiff University · ORCID：0000-0003-3576-9496

发表论文 368 篇 · 总被引 30273 次 · h-index 73

代表论文

Mechanisms of sensitivity and resistance to CDK4/CDK6 inhibitors in hormone receptor-positive breast cancer treatment (2024 · Drug Resistance Updates · 被引 74)
Targeted Inhibition of CYP11A1 in Castration-Resistant Prostate Cancer (2023 · NEJM Evidence · 被引 26)
Trilaciclib prior to FOLFOXIRI/bevacizumab for patients with untreated metastatic colorectal cancer: phase 3 PRESERVE 1 trial (2024 · JNCI Cancer Spectrum · 被引 8)
MK-5684 (ODM-208), a CYP11A1 inhibitor, in patients with metastatic castration-resistant prostate cancer (mCRPC) with and without AR-LBD mutations: CYPIDES phase 2 results. (2024 · Journal of Clinical Oncology · 被引 7)
Capivasertib/Fulvestrant in patients with HR+, HER2-low or HER2-negative locally advanced or metastatic breast cancer (2025 · Therapeutic Advances in Medical Oncology · 被引 5)
Efficacy and safety of dendrimer-enhanced (DEP) cabazitaxel (DEP CTX) in patients with advanced solid cancers in a phase 1/2 trial (P1/2). (2024 · Journal of Clinical Oncology · 被引 5)